ArticleNPJ Parkinson's disease2026
Exploring fNIRS-guided neurofeedback for supplementary motor area training in Parkinson's disease and healthy older adults.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Opportunities and challenges for deep brain stimulation electrode-guided neurofeedback for symptom mitigation in neurological and psychiatric disorders.Journal of neuroengineering and rehabilitation · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Parkinson's disease (PD) is typically treated with medication, which often leads to side effects. This study investigated a non-pharmacological approach combining motor imagery (MI) with neurofeedback (NFB) guided by functional near-infrared spectroscopy (fNIRS) to enhance supplementary motor area (SMA) activation during MI. Three groups (N = 18 each) completed four sessions: a PD-NFB group, a healthy NFB group, and a healthy control group without NFB. The NFB groups received feedback based on decreased Δ[HbR], reflecting increased brain activity. The control group performed MI without feedback. Participants in the NFB groups generally perceived NFB to be manageable. The healthy NFB group showed significantly higher SMA activation than the noNFB group. No significant differences were observed between the PD and healthy NFB groups, or between baseline and NFB-MI in PD. This first fNIRS-guided MI-NFB study in PD (German Clinical Trials Register, DRKS-ID: DRKS00022997, DOR: 2020-10-02). Shows promise for motor rehabilitation, but also highlights further research and protocol refinement.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.